Tag: chemoembolization

TRIMODALITY

HKUMed discovers new trimodality therapy for locally advanced liver cancer

A phase II clinical study on a trimodality therapy (START-FIT), conducted by the Departments of Surgery and Clinical Oncology, School of Clinical Medicine, University...

Alban Denys

Alban Denys is a French-Swiss interventional radiologist who was one of the founding members of the Society of Interventional Oncology (SIO). He has held...
Embolics

Flowing on the horizon: Liquid embolics in development

To become a mainstay liquid embolic for peripheral use, an optimal product should be easy to use, have reproducible and controllable deep penetration for...

New data demonstrate clinical experience with LifePearl microspheres in over 300...

Transarterial chemoembolization (TACE) using LifePearl (Terumo) drug-eluting embolic agents in the treatment of hepatocellular carcinoma has just been published.

International survey reveals high variability in TACE technique

Transarterial chemoembolization (TACE) is a mainstay of locoregional treatment for hepatocellular carcinoma (HCC) in the intermediate stage. “The technique for this procedure, however, continues...

Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE

Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...
Interventional News for specialists

Sorafenib: A good candidate for hepatocellular carcinoma chemoembolization

By Alexandre Laurent, Laurent Bédouet and Laurence Moine Chemoembolization with sorafenib (Bayer and Onyx Pharmaceuticals) is a promising technique for the treatment of hepatocellular carcinoma...

Canada first country to get DC Bead Lumi treatment for liver...

BTG International Canada has announced the commercial launch of DC Bead Lumi in Canada. The launch represents the first market commercialisation of DC Bead...